Is chronic hepatitis C virus infection a risk factor for breast cancer?

World Journal of Gastroenterology

Volumn 16, Issue 29, 2010, Pages 3687-3691

  Larrey, Dominique ^a   Bozonnat, Marie Cécile ^a   Kain, Ihab ^a   Pageaux, Georges Philippe ^a   Assenat, Eric ^a  

^a UNIV MONTPELLIER   (France)

Author keywords

Breast cancer; Breast tumors; Hepatitis C virus infection; Risk factor

Indexed keywords

BIOLOGICAL MARKER;

ADULT; AGED; ALCOHOL LIVER DISEASE; ARTICLE; AUTOIMMUNE HEPATITIS; BENIGN TUMOR; BREAST CANCER; BREAST CARCINOMA; BREAST CYST; BREAST DISEASE; CHOLANGITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEMOCHROMATOSIS; HEPATITIS B; HEPATITIS C; HUMAN; INFLAMMATION; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR;

EID: 77955758291     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i29.3687     Document Type: Article

References (28)

1. Pagano JS, Blaser M, Buendia MA, Damania B, Khalili K, Raab-Traub N, Roizman B. Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol 2004; 14: 453-471
2. Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009; 49: 1335-1374
3. Sherman M. Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis 2005; 25: 143-154
4. Degos F, Christidis C, Ganne-Carrie N, Farmachidi JP, Degott C, Guettier C, Trinchet JC, Beaugrand M, Chevret S. Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut 2000; 47: 131-136
5. Hassan MM, Frome A, Patt YZ, El-Serag HB. Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States. J Clin Gastroenterol 2002; 35: 266-269
6. Martinot-Peignoux M, Roudot-Thoraval F, Mendel I, Coste J, Izopet J, Duverlie G, Payan C, Pawlotsky JM, Defer C, Bogard M, Gerolami V, Halfon P, Buisson Y, Fouqueray B, Loiseau P, Lamoril J, Lefrere JJ, Marcellin P. Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy. The GEMHEP. J Viral Hepat 1999; 6: 435-443
7. Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 2000; 20: 1-16
8. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144: 705-714
9. Schöllkopf C, Smedby KE, Hjalgrim H, Rostgaard K, Panum I, Vinner L, Chang ET, Glimelius B, Porwit A, Sundström C, Hansen M, Adami HO, Melbye M. Hepatitis C infection and risk of malignant lymphoma. Int J Cancer 2008; 122: 1885-1890
10. Giordano TP, Henderson L, Landgren O, Chiao EY, Kramer JR, El-Serag H, Engels EA. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA 2007; 297: 2010-2017
11. El-Serag HB, Engels EA, Landgren O, Chiao E, Henderson L, Amaratunge HC, Giordano TP. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population- based study of U.S. veterans. Hepatology 2009; 49: 116-123
12. Montella M, Pezzullo L, Crispo A, Izzo F, Amore A, Marone U, Tamburini M, Ronga D, Chiofalo MG, Chiappetta G, Mozzillo N. Risk of thyroid cancer and high prevalence of hepatitis C virus. Oncol Rep 2003; 10: 133-136
13. Malaguarnera M, Gargante MP, Risino C, Ranno S, Berretta M, Cannizzaro MA, Costanzo M, Fricia T, Rampello E, Romano M. Hepatitis C virus in elderly cancer patients. Eur J Intern Med 2006; 17: 325-329
14. Bruno G, Andreozzi P, Graf U, Santangelo G. Hepatitis C virus: a high risk factor for a second primary malignancy besides hepatocellular carcinoma. Fact or fiction? Clin Ter 1999; 150: 413-418
15. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24: 289-293
16. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357: 1069-1075
17. Castera L, Denis J, Babany G, Roudot-Thoraval F. Evolving practices of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in France: time for new guidelines? J Hepatol 2007; 46: 528-529; author reply 529-530
18. Bakanova A, Mura T, Mourrut C, Blanc P, Pageaux GP, Remy AJ, Chiari R, Larrey D, Fabbro-Peray P, Ribard D. Le dossier informatisé des patients atteints d'hépatite C en Languedoc- Roussillon: un bilan après 29 mois de fonctionnement. Gastroenterol Clin Biol 2007; 31: A140
19. Rochefort H, Rouëssé J. [How to reduce the incidence of breast cancer] Bull Acad Natl Med 2008; 192: 161-179
20. Kelsey JL, Gammon MD. The epidemiology of breast cancer. CA Cancer J Clin 1991; 41: 146-165
21. Piscitelli P, Santoriello A, Buonaguro FM, Di Maio M, Iolascon G, Gimigliano F, Marinelli A, Distante A, Serravezza G, Sordi E, Cagossi K, Artioli F, Santangelo M, Fucito A, Gimigliano R, Brandi ML, Crespi M, Giordano A. Incidence of breast cancer in Italy: mastectomies and quadrantectomies performed between 2000 and 2005. J Exp Clin Cancer Res 2009; 28: 86
22. Chia S, Bryce C, Gelmon K. The 2000 EBCTCG overview: a widening gap. Lancet 2005; 365: 1665-1666
23. Tavani A, Gallus S, La Vecchia C, Negri E, Montella M, Dal Maso L, Franceschi S. Risk factors for breast cancer in women under 40 years. Eur J Cancer 1999; 35: 1361-1367
24. Peppercorn J. Breast cancer in women under 40 years. Oncology 2009; 23: 465-474
25. Lajous M, Boutron-Ruault MC, Fabre A, Clavel-Chapelon F, Romieu I. Carbohydrate intake, glycemic index, glycemic load, and risk of postmenopausal breast cancer in a prospective study of French women. Am J Clin Nutr 2008; 87: 1384-1391
26. Terry KL, Willett WC, Rich-Edwards JW, Michels KB. A prospective study of infertility due to ovulatory disorders, ovulation induction, and incidence of breast cancer. Arch Intern Med 2006; 166: 2484-2489
27. Casey PM, Cerhan JR, Pruthi S. Oral contraceptive use and risk of breast cancer. Mayo Clin Proc 2008; 83: 86-90; quiz 90-91
28. Hamilton R, Williams JK, Bowers BJ, Calzone K. Life trajectories, genetic testing, and risk reduction decisions in 18-39 year old women at risk for hereditary breast and ovarian cancer. J Genet Couns 2009; 18: 147-159